Literature DB >> 24768986

International typing study of Clostridium difficile.

Carl E Manzo1, Michelle M Merrigan2, Stuart Johnson3, Dale N Gerding4, Thomas V Riley5, Joseph Silva6, Jon S Brazier7.   

Abstract

We report the results of an international Clostridium difficile typing study to cross reference strain designations for seven typing methodologies and facilitate inter-laboratory communication. Four genotypic and three phenotypic methods were used to type 100 isolates and compare the results to 39 PCR ribotypes identified among the collection. Published by Elsevier Ltd.

Entities:  

Keywords:  Clostridium difficile; Genotypic typing; PCR ribotyping; Phenotypic typing; REA typing

Mesh：

Year:  2014        PMID： 24768986     DOI： 10.1016/j.anaerobe.2014.04.005

Source DB:  PubMed          Journal:  Anaerobe        ISSN： 1075-9964            Impact factor:   3.331


  3 in total

1.  Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling.

Authors:  Lorraine D Hernandez; Fred Racine; Li Xiao; Edward DiNunzio; Nichelle Hairston; Payal R Sheth; Nicholas J Murgolo; Alex G Therien
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

2.  U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.

Authors:  D R Snydman; L A McDermott; N V Jacobus; C Thorpe; S Stone; S G Jenkins; E J C Goldstein; R Patel; B A Forbes; S Mirrett; S Johnson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

3.  Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strains.

Authors:  Larry K Kociolek; Eric R Perdue; Warren N Fawley; Mark H Wilcox; Dale N Gerding; Stuart Johnson
Journal:  Anaerobe       Date:  2018-08-03       Impact factor: 3.331
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.